Vanguard Global Advisers
LLY icon

Vanguard Global Advisers’s Eli Lilly LLY Stock Holding History

Vanguard Global Advisers’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.04B Buy
1,760,510
+52,876
+3% +$62.4M 0.91% 17
2026
Q2 		$2.05B Sell
1,707,634
-27,594
-2% -$28.2M 0.95% 16
2026
Q1 		$1.6B Buy
+1,735,228
New +$1.76B 0.86% 16

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Vanguard Global Advisers's LLY Position: Q3 2026 in Review

Vanguard Global Advisers increased its Eli Lilly (LLY) stake by 3.1% in Q3 2026, buying an estimated $62.4M and bringing the position to 1,760,510 shares worth $2.04B. The position accounts for 0.91% of the portfolio, ranked #17.

Vanguard Global Advisers first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.05B in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Vanguard Global Advisers held 1,760,510 shares of Eli Lilly worth $2.04B as of Q3 2026.
  • Vanguard Global Advisers bought 52,876 Eli Lilly shares in Q3 2026, an estimated $62.4M.
  • Eli Lilly made up 0.91% of Vanguard Global Advisers's portfolio in Q3 2026, its #17 holding.
  • Vanguard Global Advisers first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Eli Lilly position peaked at $2.05B in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.